semaglutide effects on heart and the Heart: clinical insights from the SELECT Trial Semaglutide dose may matter more – increased heart rate with GLP1

GLP-1 analogues, like semaglutide (Wegovy), liraglutide (Ozempic), oral semaglutide (Rybelsus), retatrutide, and tirzepatide, have garnered attention for their remarkable impact on weight management

Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management in adults with obesity or overweight with weight-related comorbidities

Patients treated at NM Aesthetics can expect to see: Steady weight loss: Most patients lose between 15-20% of their body weight over 12 months

Make it mandatory to include protein at every meal, particularly if youre struggling to eat on semaglutide

However, large-scale, blinded placebo-controlled trials are lacking